Radiopaedia Helpers

Headings Spacing

error

"Location "

Line 28:1 · Never put spaces at either end of headings.

En Dash

error

"axial skeleton – peripheral chondrosarcoma grade 1(CS1):"

Line 32:19 · Use a hyphen-minus ('-') instead of an en-dash ('–').

Strong List Colon Position

error

"T1: low signal or isointense vs muscle"

Line 86:8 · When enboldening an intro, the colon should not be bold. 'T1: low'

"T2/STIR: high signal intensity with punctate or curvilinear signal voids indicating matrix mineralisation ^9,10"

Line 87:8 · When enboldening an intro, the colon should not be bold. 'T2/STIR: high'

"T1 C+ (Gd): peripheral and septal enhancement"

Line 88:8 · When enboldening an intro, the colon should not be bold. 'T1 C+ (Gd): peripheral'

Strong

warning

"Similar to central atypical cartilaginous tumour/chondrosarcoma grade 1, the terminology depends on the localisation. Tumours in the tubular bones of the appendicular skeleton are called ‘peripheral atypical cartilaginous tumours’, whereas tumours of the axial skeleton are called chondrosarcoma grade 1. This includes low-grade chondrosarcomas of the pelvis, scapula, and skull base ^1,2."

Line 3:165 · Generally, don't use bold in text: 'of the appendicular skeleton are called ‘peripheral atypical cartilaginous tumours’, whereas tumours of the axial skeleton are called chondrosarcoma grade 1. This includes low-grade chondrosarcomas of the pelvis, scapula, and skull base'

Emphasis

warning

"Peripheral atypical cartilaginous tumours/chondrosarcomas grade 1 (ACT/CS1) are locally aggressive cartilage matrix-forming tumours evolving at the surface of bone within the cartilaginous cap of pre-existing osteochondromas, especially in the setting of multiple osteochondromas and EXT1 or EXT2 germline mutations ^1,3."

Line 21:288 · Italics should be used only in exceptional circumstances: 'EXT1 or EXT2'

"Individuals with osteochondromas in particular multiple osteochondromas and germline mutations in EXT1 or EXT2 are at risk of tumour progression to secondary peripheral chondrosarcoma ¹. Estimated risk:"

Line 23:102 · Italics should be used only in exceptional circumstances: 'EXT1 or EXT2'

"Secondary peripheral chondrosarcomas are associated with germline mutations in EXT1 or EXT2 with a proportion of EXT1 or EXT2 mutations among all EXT alleles of about 40% and coexisting EXT-mutant and EXT-wildtype cells. The wild-type cells are thought to be the cell type prone to tumour progression ^1,2. Mutations in cell-cycle regulatory genes such as CDKN2A are also thought to be involved ¹."

Line 68:83 · Italics should be used only in exceptional circumstances: 'EXT1 or EXT2 with a proportion of EXT1 or EXT2 mutations among all EXT alleles of about 40% and coexisting EXT-mutant and EXT-wildtype cells. The wild-type cells are thought to be the cell type prone to tumour progression 1,2. Mutations in cell-cycle regulatory genes such as CDKN2A'

Acronyms

warning

"Secondary peripheral chondrosarcomas are associated with germline mutations in EXT1 or EXT2 with a proportion of EXT1 or EXT2 mutations among all EXT alleles of about 40% and coexisting EXT-mutant and EXT-wildtype cells. The wild-type cells are thought to be the cell type prone to tumour progression ^1,2. Mutations in cell-cycle regulatory genes such as CDKN2A are also thought to be involved ¹."

Line 68:186 · 'EXT' has no definition. Spell it out if it's unfamiliar to the audience.

"Secondary peripheral chondrosarcomas are associated with germline mutations in EXT1 or EXT2 with a proportion of EXT1 or EXT2 mutations among all EXT alleles of about 40% and coexisting EXT-mutant and EXT-wildtype cells. The wild-type cells are thought to be the cell type prone to tumour progression ^1,2. Mutations in cell-cycle regulatory genes such as CDKN2A are also thought to be involved ¹."

Line 68:226 · 'EXT' has no definition. Spell it out if it's unfamiliar to the audience.

"Secondary peripheral chondrosarcomas are associated with germline mutations in EXT1 or EXT2 with a proportion of EXT1 or EXT2 mutations among all EXT alleles of about 40% and coexisting EXT-mutant and EXT-wildtype cells. The wild-type cells are thought to be the cell type prone to tumour progression ^1,2. Mutations in cell-cycle regulatory genes such as CDKN2A are also thought to be involved ¹."

Line 68:241 · 'EXT' has no definition. Spell it out if it's unfamiliar to the audience.

Headings Valid

warning

Expected headings

H1 Terminology
H1 Usage
H1 Epidemiology
H2 Risk factors
H2 Associations
H1 Clinical presentation
H2 Complications
H1 Diagnosis
H2 Diagnostic criteria
H2 Diagnostic clues
H1 Pathology
H2 Aetiology
H2 Location
H2 Classification
H2 Macroscopic appearance
H2 Microscopic appearance
H2 Immunophenotype
H2 Markers
H2 Genetics
H1 Radiographic features
H2 Plain radiograph
H2 Mammography
H2 Antenatal ultrasound
H2 Transoesophageal echocardiography
H2 Ultrasound
H2 CT
H3 Dual-energy CT
H2 Angiography (DSA)
H2 MRI
H2 CT/MRI
H2 Nuclear medicine
H3 PET-CT
H3 PET-MRI
H1 Radiology report
H1 Treatment and prognosis
H2 Complications
H1 History and etymology
H1 Differential diagnosis
H2 Clinical differential diagnosis
H1 Practical points
H1 See also

"Location "

Line 28:1 · "Location " is not a recognised heading for this article type.

"Plain radiograph/CT"

Line 71:1 · "Plain radiograph/CT" is not a recognised heading for this article type.

"Signal characteristics"

Line 84:1 · "Signal characteristics" is not a recognised heading for this article type.

"Complications"

Line 111:1 · "Complications" is under the wrong parent heading (found under "Treatment and prognosis").

Biographical Lifespan

suggestion

"History and etymology"

Line 113:1 · A bold element in the History and etymology section should be a person; it would be useful to have their lifespan details: '<h4>History and etymology</h4> Chondrosarcomas in general were first described by the American bone pathologists Louis Liechtenstein '

Lint: peripheral-atypical-cartilaginous-tumour-low-grade-peripheral-chondrosarcoma-2